Stryker Launches PROstep MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal cuneiform joint. The system will debut at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Louisville, Ky., Sept. 20-23 (booth no. 101).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230919818115/en/
Stryker's PROstep MIS Lapidus is a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal cuneiform joint. (Graphic: Business Wire)
Traditionally, surgeons performing Lapidus bunion procedures use an open approach, but minimally invasive surgery techniques are being adopted in numerous surgical specialties because of the surgeon and patient advantages.1,2 PROstep MIS Lapidus offers powerful fixation stability through a minimal incision. The new technology features MIS joint preparation, triplanar reduction, and a three-screw construct designed to create a tension band for biomechanical stability.
“This procedure can be a better option for patients who are worried about cosmetic scarring from surgery and can mitigate the potential loss of correction caused by improper bone healing,” said Dr. Alastair Younger, Head of the Distal Extremities Division at the University of British Columbia. “I appreciate having a viable minimally invasive surgery option that provides surgeons and their patients more options for treating bunions.”
Benefits of the PROstep MIS Lapidus system include:
- 2.5% decrease in recurrence compared to open Lapidus procedures3
- 9% reduction in non-union rates as a result of MIS Lapidus joint preparation3
- 76% reduction in scar size compared to open bunion correction procedures4
- Less opioid usage post-op compared to open Lapidus procedures5
Lesen Sie auch
“PROstep MIS Lapidus puts the power back in our surgeon customers' hands to make the best decision for their patients,” said Patrick Fisher, Vice President and General Manager for Stryker’s Foot and Ankle business unit. “At Stryker, we're continuing to expand our surgery options to support our commitment to advancing minimally invasive foot and ankle surgery.”